Cheryl Ann Tingle

Title: Cheryl Ann Tingle: Innovator in Pharmaceutical Formulations

Introduction

Cheryl Ann Tingle is a notable inventor based in Mooresville, IN (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in the stabilization of complex compounds. Her work has implications for the development of effective medications.

Latest Patents

Cheryl Ann Tingle holds 1 patent for her invention titled "Stabilized formulations of 6-hydroxy-3-(-4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene and salts thereof." This invention focuses on pharmaceutical formulations that contain 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene or its salts. The formulations are stabilized against oxidation and other forms of decomposition by incorporating stabilizing agents such as methionine, acetylcysteine, cysteine, or their salts.

Career Highlights

Cheryl is associated with Eli Lilly and Company, a leading pharmaceutical company known for its innovative research and development. Her work at Eli Lilly has allowed her to contribute to advancements in drug formulation and stability, enhancing the efficacy of pharmaceutical products.

Collaborations

Cheryl has collaborated with notable colleagues, including Fadia Najjar Bashore and Kerry John Hartauer. These collaborations have fostered a productive environment for innovation and development within the pharmaceutical sector.

Conclusion

Cheryl Ann Tingle's contributions to pharmaceutical formulations exemplify the importance of innovation in medicine. Her patent work and collaborations highlight her role as a key player in the advancement of drug stability and efficacy.